A woman from Wales experienced a miraculous recovery from cancer after being prescribed a new wonder drug. Carrie Downey’s stage three bowel cancer vanished within six months of taking dostarlimab. This targeted treatment, a form of immunotherapy, helped her immune system destroy the cancer. Dostarlimab is currently being clinically trialled but has already shown remarkable results, eliminating the need for surgery, radiotherapy, or chemotherapy.
Ms. Downey, a 42-year-old civil servant, was diagnosed with cancer last year. She sought medical attention for pains from a previous hernia mesh implant, which led doctors to discover her cancer. She was then referred to Dr. Craig Barrington, a consultant oncologist, who prescribed dostarlimab for her treatment. Over a period of six months, Ms. Downey received three-weekly IV administrations of dostarlimab, each lasting around 30 minutes.
During her treatment, scans showed significant shrinkage of the tumor. At the end of the course, there was no evidence of the disease. Two subsequent scans have confirmed this positive outcome. Now, Ms. Downey, a single mother with a 17-year-old son, is preparing to return to work after her successful treatment.
Expressing gratitude to Dr. Barrington and his team, Ms. Downey credits them for giving her life back and looks forward to forever being thankful. In a similar case last year, 18 rectal cancer patients received the same drug for six months, resulting in the complete eradication of cancer in every patient.